Diseases & Disorders
(G30)
990 on File
INTERNATIONAL NEUROENDOCRINE CANCER ALLIANCE INC
Financial strength (30%)
86/100
Reliability (20%)
50/100
Effectiveness (25%)
68/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$398K
Total Revenue
$362K
Total Expenses
$363K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
91.0%
Fundraising Efficiency
N/A
Operating Reserve
12.04x
Liability-to-Asset
4.8%
Revenue Diversification
95.8%
Executive Compensation
$0
Compared with Peers
FY 2025
Compared with 693 similar organizations
(United States, Diseases & Disorders, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
91.0% | 83.5% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
9.0% | 10.0% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
12.0 mo | 11.9 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
4.8% | 0.6% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
95.8% | 93.4% |
P10P90
|
Below median |
|
Surplus margin
Surplus as a share of revenue
|
9.1% | 4.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $398K | $362K | $363K | 91.0% | 0 |
| 2023 | $265K | $271K | $315K | 88.9% | 0 |
| 2022 | $257K | $266K | $321K | 87.9% | 0 |
| 2021 | $363K | $175K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.